Sage Capital Management »

Oramed Pharm shares owned by Sage Capital Management

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by Sage Capital Management from 13F filings

Historical chart of Sage Capital Management investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by Sage Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by Sage Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $41k 17k 2.42
2024-09-30 $41k 17k 2.44
2024-06-30 $43k 17k 2.57
2024-03-31 $49k 17k 2.92

More positions owned by Sage Capital Management

NVIDIA Corporation (NVDA)
Global X Fds Us Infr Dev Etf (PAVE)
Select Sector Spdr Tr Technology (XLK)
Invesco Exchange Traded Fd T Water Res Etf (PHO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amplify Etf Tr Amplify Cybersec (HACK)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Spdr Ser Tr Factst Inv Etf (XITK)
Wisdomtree Tr Us Midcap Divid (DON)
Spdr Ser Tr Bbg Conv Sec Etf (CWB)
Ea Series Trust Strive 500 Etf (STRV)
International Business Machines (IBM)

View all positions for Sage Capital Management

Top funds holding Oramed Pharm

BML Capital Management
Murchinson
Boothbay Fund Management
Rathbones Brothers
Two Sigma Advisers
Peapod Lane Capital
Bank of America Corporation
Renaissance Technologies
Dimensional Fund Advisors
UBS Group
Two Sigma Investments
Connor, Clark & Lunn Investment Management
Susquehanna International
BlackRock
Citadel Advisors

View all funds holding Oramed Pharm